Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics. Ketchemen JP, Babeker H, Tikum AF, Nambisan AK, et al. Br J Cancer 2023 Apr 24. doi: 10.1038/s41416-023-02272.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ketchemen JP, Babeker H, Tikum AF, Nambisan AK, et al. Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics. Br J Cancer 2023 Apr 24. doi: 10.1038/s41416-023-02272.
PMID: 37095184